Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.

Saved in:
Bibliographic Details
Title: Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.
Authors: Lin DS; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan., Lo HY; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan., Yang CW; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. yang.chung.wei@gmail.com.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. yang.chung.wei@gmail.com., Wu CC; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. chihchengwumd@gmail.com.; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. chihchengwumd@gmail.com.; Institute of Biomedical Engineering, National Tsing-Hua University, Hsinchu, Taiwan. chihchengwumd@gmail.com.; Institute of Cellular and System Medicine, National Health Research Institute, Zhunan, Taiwan. chihchengwumd@gmail.com.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 83-96. Date of Electronic Publication: 2025 Aug 25.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40855136
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+DS%22">Lin DS</searchLink>; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lo+HY%22">Lo HY</searchLink>; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+CW%22">Yang CW</searchLink>; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. yang.chung.wei@gmail.com.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. yang.chung.wei@gmail.com.<br /><searchLink fieldCode="AU" term="%22Wu+CC%22">Wu CC</searchLink>; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. chihchengwumd@gmail.com.; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, No. 25, Lane 442, Section 1, Jingguo Rd, North District, Hsinchu City, 300, Taiwan. chihchengwumd@gmail.com.; Institute of Biomedical Engineering, National Tsing-Hua University, Hsinchu, Taiwan. chihchengwumd@gmail.com.; Institute of Cellular and System Medicine, National Health Research Institute, Zhunan, Taiwan. chihchengwumd@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 83-96. <i>Date of Electronic Publication: </i>2025 Aug 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40855136
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40256-025-00760-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 83
    Titles:
      – TitleFull: Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin DS
      – PersonEntity:
          Name:
            NameFull: Lo HY
      – PersonEntity:
          Name:
            NameFull: Yang CW
      – PersonEntity:
          Name:
            NameFull: Wu CC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-187X
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions
              Type: main
ResultId 1